Organon Pharma Indonesia Tbk. vs Mandom Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Mandom Indonesia Tbk. trades at Rp2,600 (market cap 1.04T, 900 24h volume). The key difference: Mandom Indonesia Tbk. is far larger — about 10× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TCID | |
|---|---|---|
Market Cap | 104.4B | 1.04T |
Volume | — | 900 |
Lot | — | 9 |
Turnover | — | 2.32M |
Average Price | — | 2,574.44 |
Value | — | 2.32M |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT. Mandom Indonesia Tbk (the Company), formely PT Tancho Indonesia Tbk was incorporated under the framework of the Foreign Capital Investment law dated November 5, 1969.The Company’s Articles of Association have been amended several times, including change of par value from Rp. 1000 to Rp. 500,- and change in name to PT Tancho Indonesia Tbk. Then increase in the authorized share capital to Rp 312 billion and issued and paid up capital to Rp. 78 billion. At an Extraordinary General Meeting of Share Holders dated November 2000, it was resolved to change the company’s name to PT Mandom Indonesia Tbk.The company is located in Jakarta and factories are located in Jakarta and Industrial Estate MM2100, Cibitung, West Java. The Company commenced commercial production in April 16, 1971.
Read more on TCID →